Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics

John Clarkson's Biography

John Clarkson, CEO, Atlas Genetics Limited

John Clarkson has been in healthcare and diagnostics businesses for the past 15 years and has a background in molecular biology and microbiology. He co-founded Molecular Sensing, where he was Technical Director.  Following the development of their DNA analysis system, he joined the US-based diagnostics company Osmetech as Instrument Systems Director when they acquired Molecular in 2004.  John is now Chief Executive of Atlas Genetics, which is developing rapid tests for infectious diseases such as the sexually transmitted diseases Chlamydia and gonorrhoea.  Atlas Genetics was founded in 2005 as a joint spin-out from the University of Bath and Osmetech plc, and is funded by development contract revenue, VC and private investment. The company raised £17m in 2011 in a series B financing round led by Novartis Venture Funds.

John Clarkson Image

POC Nucleic Acid Tests for Infectious Diseases

Thursday, 10 May 2012 at 14:45

Add to Calendar ▼2012-05-10 14:45:002012-05-10 15:45:00Europe/LondonPOC Nucleic Acid Tests for Infectious

This talk will overview the technical developments that are making molecular Point-Of-Care testing a reality, and also describe the Atlas Genetics Velox™ system, a unique POC diagnostic platform for ultra-rapid, inexpensive and accurate diagnosis of infectious diseases.

Add to Calendar ▼2012-05-10 00:00:002012-05-11 00:00:00Europe/LondonPoint-of-Care